The generic name of Unipin is Atorvastatin Calcium Tablets, a lipid-lowering drug, and taking Atorvastatin Calcium Tablets may have an effect on blood glucose. Hyperglycemic reactions, abnormal glucose tolerance, elevated glycosylated hemoglobin levels, new-onset diabetes mellitus, and worsening of glycemic control have been reported in postmarketing surveillance of statins, and hypoglycemic reactions have been reported with some statins. Atorvastatin affects insulin sensitivity, influencing insulin secretion and leading to elevated blood glucose. In addition, atorvastatin affects the absorption and utilization of glucose by skeletal muscle, which can also increase blood glucose. Therefore, blood glucose levels need to be monitored while taking Atorvastatin Calcium Tablets. It should be noted that Atorvastatin Calcium Tablets are contraindicated in patients with active liver disease, patients with persistent elevation of unexplained aminotransferases (AST and/or ALT), pregnant women or women of childbearing age who are likely to conceive, and breastfeeding women. Patients need to follow medical advice when applying Atorvastatin Calcium Tablets to avoid adverse effects.